Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

Fig. 3

Predicted risk group vs 5-year progression free survival in the combined GCB dataset. Risk groups were obtained by taking the average predicted risk score across validation folds for the repeated cross-validation for the multivariate Cox models using (a) miRNA probes either alone or (b) in combination with IPI and splitting these into tertiles. Figure was constructed using the R package survminer v0.4.6

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us